Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients
Clinical trial NCT05577364 · UNKNOWN
Trial details
- NCT number
- NCT05577364
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-12-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.